The effect of demlatonin on the treatment of sleep disorders in hemodialysis patients
Phase 2
Recruiting
- Conditions
- ESRD.Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal diseaseI12.0
- Registration Number
- IRCT20220112053698N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Complete consent to participate in this study
Patients with ESRD with a history of at least 3 months of dialysis (3 times a week for 4 hours)
Age 16 years and older
Exclusion Criteria
STOP-BANG = 3 values that are in favor of the possibility of obstructive sleep apnea.
Diagnosed with neurological disorders
People with craniofacial disorders and neurological defects, whether acquired or congenital
Addiction or regular use of sleeping pills
Taking anticoagulants and anticonvulsants
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep quality. Timepoint: Before and after study. Method of measurement: Standard sleep quality questionnaire.
- Secondary Outcome Measures
Name Time Method